Beyond T2DM, the Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes trial is assessing whether GLP-1 RAs can meaningfully reduce MACE, HF hospitalizations, and other cardiovascular endpoints in patients with type 1 diabetes, a population generally underrepresented in cardiovascular prevention studies [66]
Some have also reported mild anxiety or agitation
References: Langendonk, J
Uso Sencillo: Solo necesitas tomar 2 cpsulas al da, preferentemente durante las comidas
Comirnaty, mNexspike and Spikevax specifically target the LP.8.1 sublineage
However, this portal glucose sensor may still require gut input, as these effects appear to be mediated by vagal GLP-1R activation 60,61,62